Join to View Full Profile
375 Wampanoag TrlSuite 202aRiverside, RI 02915
Phone+1 401-649-4030
Fax+1 401-649-4031
Dr. Moss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Steven Moss, MD, is a gastroenterologist based in Riverside, RI. He completed his fellowship in gastroenterology at Icahn School of Medicine at Mount Sinai/St Luke’s-Roosevelt Hospital Center from 1993 to 1995 and graduated from the University of London Faculty of Medicine in 1985. Dr. Moss has authored several publications primarily focused on Helicobacter pylori, including guidelines and studies on its treatment and management. He has been recognized as a Regional Top Doctor by Castle Connolly in 2014 and is a Fellow of the American Gastroenterological Association. Additionally, he received the CMS Meaningful Use Stage 1 Certification for EHR from 2011 to 2013.
Education & Training
Icahn School of Medicine at Mount Sinai/St Luke’s-Roosevelt Hospital CenterFellowship, Gastroenterology, 1993 - 1995
University of London Faculty of MedicineClass of 1985
Certifications & Licensure
RI State Medical License 2000 - 2026
FL State Medical License 2021 - 2023
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2013
- Fellow (AGAF) American Gastroenterological Association, 2009
Publications & Presentations
PubMed
- High Economic Burden Yet Low Clinical Value: Why Is so Much Sucralfate Prescribed?Neha Wadhavkar, Laura Varnum, Steven F Moss
Basic & Clinical Pharmacology & Toxicology. 2025-07-01 - 1 citationsEditorial: H. pylori Antimicrobial Susceptibility Testing-An Expanding Toolbox.Suvithan Rajadurai, Steven F Moss
Alimentary Pharmacology & Therapeutics. 2025-02-01 - 91 citationsACG Clinical Guideline: Treatment of Helicobacter pylori Infection.William D Chey, Colin W Howden, Steven F Moss, Douglas R Morgan, Katarina B Greer
The American Journal of Gastroenterology. 2024-09-01
Journal Articles
- Correction: ACG Clinical Guideline: Treatment of Helicobacter Pylori InfectionColin W Howden, Steven F Moss, Nature
Press Mentions
Treating Helicobacter Pylori Infection Reduces Gastric Cancer RiskFebruary 14th, 2023- American College of Gastroenterology, Oct. 22-27November 9th, 2021
- Top 10 from ACG: Clostridioides Difficile, CRC Screening, Health DisparitiesNovember 6th, 2021
- Join now to see all
Grant Support
- Genome-Wide Fine-Mapping Of H. Pylori-Stimulated Human T Cell ResponsesNational Institute Of Allergy And Infectious Diseases2009–2011
- Trefoil Binding Proteins In Gastric CarcinogenesisNational Center For Research Resources2010
- P27 &Apoptosis Resistance In Gastric CancerNational Cancer Institute2006–2010
- Gastric Cancer Induced By H Pylori In P27 Deficient MiceNational Cancer Institute2008–2009
- Cobre: Rih: Theme B: H Pylori In Gastric CarcinogenesisNational Center For Research Resources2005–2009
- Cobre: Rih: Theme B: H. Pylori In Gastric CarcinogenesisNational Center For Research Resources2004
- H Pylori Mediated Gastric CarcinogenesisNational Center For Research Resources2002
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
